Neta Erez-Alon

Title: Neta Erez-Alon: Innovator in Anti-Tumor Immunity

Introduction

Neta Erez-Alon is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions aimed at inducing anti-tumor immunity. With a total of 2 patents, Erez-Alon is recognized for his innovative approaches to cancer treatment.

Latest Patents

Erez-Alon's latest patents focus on methods for inducing anti-tumor immunity and immune responses to p53 in mammals. The inventions involve administering an effective amount of at least one immunogen, which is preferably a peptide ranging from 7 to 30 amino acid residues in length. This peptide contains sequences from the CDR2 or CDR3 of the heavy chain, or the CDR3 of the light chain of an anti-p53 monoclonal antibody. These advancements hold promise for enhancing cancer therapies and improving patient outcomes.

Career Highlights

Erez-Alon is affiliated with Yeda Research and Development Co. Ltd., where he continues to push the boundaries of immunological research. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.

Collaborations

Erez-Alon collaborates with esteemed colleagues, including Irun R Cohen and Varda Rotter, who contribute to his research endeavors. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Neta Erez-Alon is a key figure in the field of immunology, with a focus on anti-tumor immunity. His innovative patents and collaborative efforts position him as a leader in the quest for effective cancer treatments.